Related references
Note: Only part of the references are listed.Diabetic retinopathy
Teresa Barth et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2021)
Diabetic Retinopathy
Teresa Barth et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2021)
Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy
Hui-Jin Chen et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
Incidence and progression of diabetic retinopathy: a systematic review
Charumathi Sabanayagam et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy
Jennifer K. Sun et al.
OPHTHALMOLOGY (2019)
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes
John F. Payne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy Outcomes from the Randomized RECOVERY Trial
Charles C. Wykoff et al.
OPHTHALMOLOGY RETINA (2019)
Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study)
Joao Figueira et al.
OPHTHALMOLOGY (2018)
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy Factors Associated with Vision and Edema Outcomes
Susan B. Bressler et al.
OPHTHALMOLOGY (2018)
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial
Jeffrey G. Gross et al.
JAMA OPHTHALMOLOGY (2018)
The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema
Gabriele E. Lang et al.
ACTA OPHTHALMOLOGICA (2018)
Different lasers and techniques for proliferative diabetic retinopathy
Tanya Moutray et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Sobha Sivaprasad et al.
LANCET (2017)
Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab
Susan B. Bressler et al.
OPHTHALMOLOGY (2017)
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy
Jeffrey G. Gross et al.
JAMA OPHTHALMOLOGY (2017)
Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2017)
Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial
Wesley T. Beaulieu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Diabetic retinopathy
Tien Y. Wong et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Effect of Doxycycline vs Placebo on Retinal Function and Diabetic Retinopathy Progression in Patients With Severe Nonproliferative or Non-High-Risk Proliferative Diabetic Retinopathy A Randomized Clinical Trial
Ingrid U. Scott et al.
JAMA OPHTHALMOLOGY (2014)
Diabetic retinopathy: pathogenesis, clinical grading, management and future developments
L. Z. Heng et al.
DIABETIC MEDICINE (2013)
Classification of diabetic retinopathy and diabetic macular edema
Lihteh Wu et al.
WORLD JOURNAL OF DIABETES (2013)
The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema
Paul Mitchell et al.
OPHTHALMOLOGY (2011)
Share Paper
